HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

R Eastell Selected Research

collagen type I trimeric cross-linked peptide

1/2021A Multicenter Study to Evaluate Harmonization of Assays for C-Terminal Telopeptides of Type I Collagen (ß-CTX): A Report from the IFCC-IOF Committee for Bone Metabolism (C-BM).
3/2013Evaluation of urinary N-telopeptide of type I collagen measurements in the management of osteoporosis in clinical practice.
10/2011Very low birth weight survivors have reduced peak bone mass and reduced insulin sensitivity.
2/2011Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards.
6/2003Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate.
7/2000Biochemical markers as predictors of rates of bone loss after menopause.
1/2000Ethnic and gender differences in bone mineral density and bone turnover in young adults: effect of bone size.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


R Eastell Research Topics

Disease

30Osteoporosis
06/2022 - 01/2000
21Bone Resorption
01/2021 - 01/2000
9Postmenopausal Osteoporosis
04/2019 - 01/2000
3Metabolic Bone Diseases (Osteopenia)
01/2016 - 02/2001
2Type 2 Diabetes Mellitus (MODY)
12/2018 - 08/2015
2Osteoporotic Fractures
01/2018 - 01/2013
2Hypercalcemia (Milk Alkali Syndrome)
01/2017 - 02/2009
2Colonic Neoplasms (Colon Cancer)
03/2013 - 11/2012
2Neoplasms (Cancer)
11/2012 - 06/2009
2Weight Gain
10/2011 - 08/2001
1Acute Kidney Injury (Acute Renal Failure)
03/2022
1Hypothyroidism
01/2018
1Osteomyelitis
10/2017
1Osteonecrosis (Kienbock's Disease)
10/2017
1Bone Diseases (Bone Disease)
11/2016
1Obesity
02/2015
1Hip Fractures (Intertrochanteric Fractures)
01/2013
1Lung Diseases (Lung Disease)
11/2012
1Colorectal Neoplasms (Colorectal Cancer)
11/2012
1Insulin Resistance
10/2011
1Breast Neoplasms (Breast Cancer)
06/2009
1Hyperparathyroidism
02/2009
1Wounds and Injuries (Trauma)
12/2008
1Fatigue
09/2007
1Hypogonadism (Hypergonadotropic Hypogonadism)
06/2006
1Congenital Abnormalities (Deformity)
06/2003
1Colles' Fracture
11/2001
1Birth Weight (Birth Weights)
01/2001
1Primary Hyperparathyroidism
05/2000

Drug/Important Bio-Agent (IBA)

13Diphosphonates (Bisphosphonates)IBA
06/2022 - 01/2001
8Risedronic Acid (Actonel)FDA LinkGeneric
06/2018 - 01/2000
8Collagen Type I (Type I Collagen)IBA
03/2013 - 01/2000
7collagen type I trimeric cross-linked peptideIBA
01/2021 - 01/2000
6Alendronate (Alendronate Sodium)FDA LinkGeneric
06/2018 - 06/2011
6Biomarkers (Surrogate Marker)IBA
10/2011 - 01/2000
5Vitamin DFDA LinkGeneric
01/2017 - 11/2001
5GlucocorticoidsIBA
06/2015 - 01/2000
4Procollagen Type IIBA
10/2011 - 01/2000
4Alkaline PhosphataseIBA
10/2011 - 01/2000
4CalciumIBA
10/2011 - 01/2001
4SteroidsIBA
10/2011 - 12/2000
3CreatinineIBA
03/2022 - 07/2000
3Parathyroid Hormone (Parathormone)IBA
01/2017 - 01/2001
3Hormones (Hormone)IBA
02/2015 - 12/2000
3MineralsIBA
03/2013 - 01/2000
3Estrogens (Estrogen)FDA Link
01/2007 - 12/2000
2hydroxide ionIBA
01/2017 - 03/2014
225-hydroxyvitamin DIBA
01/2017 - 03/2014
2CytokinesIBA
11/2016 - 01/2007
2Raloxifene Hydrochloride (Evista)FDA Link
01/2016 - 06/2011
2Indicators and Reagents (Reagents)IBA
03/2013 - 03/2000
2Glucose (Dextrose)FDA LinkGeneric
10/2011 - 09/2007
2Testosterone (Sustanon)FDA Link
06/2006 - 12/2000
2CollagenIBA
01/2001 - 03/2000
2deoxypyridinolineIBA
07/2000 - 01/2000
2OsteocalcinIBA
01/2000 - 01/2000
1Zoledronic Acid (Zometa)FDA Link
03/2022
1Edetic Acid (EDTA)FDA Link
01/2021
1NitrogenIBA
01/2020
1Ibandronic Acid (Boniva)FDA Link
06/2018
1ElementsIBA
01/2018
1Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
01/2018
1Thyroxine (Levothyroxine)FDA LinkGeneric
01/2018
1Cytokine Receptors (Cytokine Receptor)IBA
11/2016
1Cathepsin KIBA
01/2016
1ONO-5334IBA
01/2016
1Dipeptidyl-Peptidase IV InhibitorsIBA
08/2015
1SodiumIBA
08/2015
1Metformin (Glucophage)FDA LinkGeneric
08/2015
1Hypoglycemic Agents (Hypoglycemics)IBA
08/2015
1Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
08/2015
1ThiazolidinedionesIBA
08/2015
1Glucagon-Like Peptide-1 Receptor AgonistsIBA
08/2015
1Pharmaceutical PreparationsIBA
01/2013
1Insulin-Like Growth Factor I (IGF-1)IBA
10/2011
1Teriparatide (Parathar)FDA Link
06/2011
1Calcitriol Receptors (Calcitriol Receptor)IBA
03/2010
1LasofoxifeneIBA
12/2009
1Selective Estrogen Receptor Modulators (SERM)IBA
12/2009
1Aromatase InhibitorsIBA
06/2009
1TamoxifenFDA LinkGeneric
06/2009
1Fulvestrant (Faslodex)FDA Link
06/2009
1ProcollagenIBA
06/2009
1Insulin (Novolin)FDA Link
09/2007
1antineoplaston A10 (A 10)IBA
01/2007
1OsteoprotegerinIBA
11/2003
1RANK LigandIBA
11/2003
1Calcitonin (Calcitonin, Eel)FDA LinkGeneric
11/2001
1procollagen type I carboxy terminal peptide (PICP)IBA
08/2001
1procollagen Type III-N-terminal peptide (PIIP)IBA
08/2001
1Collagen Type III (Type III Collagen)IBA
08/2001
1Biological ProductsIBA
01/2001
1Interleukin-6 (Interleukin 6)IBA
05/2000

Therapy/Procedure

15Therapeutics
06/2022 - 01/2000
1Fracture Fixation
05/2021
1Glycemic Control
12/2018
1Aftercare (After-Treatment)
06/2011
1Hormone Replacement Therapy (Therapy, Hormone Replacement)
09/2006
1Secondary Prevention
11/2001
1Parathyroidectomy
05/2000